ArticleESC heart failure2015

The impact of cisplatinum-based chemotherapy on ventricular function and cardiovascular risk factors in female survivors after malignant germ cell cancer.

Klaus Murbraech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.